Govt bans popular animal painkiller after toxicity seen in vultures

In the study, two vultures were given Nimesulide, researchers observed that the treated birds showed elevated uric acid levels, a known marker of kidney failure, and both died within two days

vulture
Photo: Pexels
Abhijeet Kumar New Delhi
3 min read Last Updated : Jan 03 2025 | 4:22 PM IST
The Centre has prohibited the production, sale, and distribution of all Nimesulide formulations — commonly used as an animal painkiller — after research by the Indian Veterinary Research Institute (IVRI) in Izatnagar, Bareilly, confirmed its harmful effects on vultures, reported The Times of India. 
 
The decision followed controlled experiments in Haryana, where two Himalayan griffon vultures (Gyps himalayensis) were administered doses of Nimesulide similar to those found in the carcasses of livestock treated with the drug.
 
In the study, two vultures were given Nimesulide, while two others were administered saline as a control. Researchers observed that the treated birds showed elevated uric acid levels, a known marker of kidney failure, and both died within two days. Scientists noted that this rapid reaction was consistent with poisoning caused by other non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac and ketoprofen.
 
Quoting Abhijeet Pawde, who led the study during 2023-24, The Times of India mentioned that the importance of banning such drugs is to prevent vulture species from going extinct. He explained that their research demonstrated the high lethality of Nimesulide to vultures when they consume contaminated carcasses.
 

Nimesulide banned in several countries 

The Central Drugs Standard Control Organisation (CDSCO), under the Department of Health and Family Welfare, implemented the ban through a gazette notification on Monday under the Drugs and Cosmetics Act, 1940. However, reports indicate that the drug is still accessible in rural areas, raising concerns about enforcement. Veterinary specialists have reiterated the need for stricter monitoring to ensure compliance.
 
Nimesulide, widely used for treating animals such as cattle, pigs, and horses, has been banned for pediatric use in several countries due to safety issues. Pawde pointed out that formulations for animals might contain impurities absent in human medicines, potentially increasing their toxicity.
 
Experts have recommended safer alternatives like meloxicam and tolfenamic acid, citing their effectiveness and affordability. Another researcher, M Karikalan, argued that replacing toxic drugs like Nimesulide with safer options was both practical and necessary.
 
Future research will include investigating the toxicity of other drugs, such as paracetamol, to protect vultures and other scavenger species crucial to ecological balance.
 

Is Nimesulide banned for humans in India? 

In June last year, the government banned a fixed-dose combination of Nimesulide and Paracetamol dispersible tablets, citing a lack of therapeutic justification and potential risks to people. The banned combinations included medicines for common infections, cough, and fever, such as Chlopheniramine Maleate + Codeine Syrup, Pholcodine + Promethazine, and Amoxicillin + Bromhexine, among others.
 
An expert committee recommended the ban, stating that these combinations posed risks to human health and served no justified medical purpose. The committee concluded that, in the interest of public safety, the manufacture, sale, or distribution of these combinations under the Drugs and Cosmetics Act, 1940, should be prohibited, with no scope for regulated use.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :BS Web Reportsdrug banpainkillers

First Published: Jan 03 2025 | 4:22 PM IST

Next Story